Similar Papers

Paper Title
Journal
Date
Author
Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study
Christine Brunner ... Daniel Egle
The Breast | VOL. 64
Christine Brunner, et. al.Christine Brunner ... Daniel Egle
30 Apr 2022
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device.
Rebecca Pedersini ... Mara Ardine
International Journal of Nursing Practice | VOL. 27
Rebecca Pedersini, et. al.Rebecca Pedersini ... Mara Ardine
22 Sep 2020
Application of scalp cooling cap to reduce alopecia in breast cancer patients with neoadjuvant chemotherapy
...
-
, et. al. ...
01 Dec 2018
Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
Luisa Carbognin ... Alejandro Martin Sanchez
Current Oncology | VOL. 29
Luisa Carbognin, et. al.Luisa Carbognin ... Alejandro Martin Sanchez
30 Sep 2022
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Reply to the Letter to the Editor regarding ‘PFS, OS or toxicity: what is the most important factor in the treatment of EGFR-mutated lung cancer?’ by T. Nishimura and H. Fujimoto
E Felip ... S.-H Lee
Annals of Oncology | VOL. 36
E Felip, et. al.E Felip ... S.-H Lee
01 Feb 2025
Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial
Marcela Carausu ... Michail Ignatiadis
Annals of Oncology | VOL. 36
Marcela Carausu, et. al.Marcela Carausu ... Michail Ignatiadis
01 Feb 2025
FOxTROT: is anti-EGFR a good dancing partner?
Clara Montagut ... Joana Vidal
Annals of Oncology | VOL. -
Clara Montagut, et. al.Clara Montagut ... Joana Vidal
01 Feb 2025
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.